Robeco Schweiz’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.41M Sell
52,254
-9,507
-15% -$849K 0.09% 109
2026
Q1
$4.44M Sell
61,761
-39,748
-39% -$3.06M 0.09% 109
2025
Q4
$8.06M Buy
101,509
+8,435
+9% +$665K 0.18% 98
2025
Q3
$7.02M Sell
93,074
-9,508
-9% -$652K 0.16% 100
2025
Q2
$7.08M Sell
102,582
-25,438
-20% -$1.67M 0.16% 101
2025
Q1
$8.67M Hold
128,020
0.21% 93
2024
Q4
$5.75M Hold
128,020
0.12% 103
2024
Q3
$8.05M Hold
128,020
0.15% 99
2024
Q2
$7.56M Hold
128,020
0.15% 96
2024
Q1
$10.2M Sell
128,020
-57,000
-31% -$4.35M 0.18% 86
2023
Q4
$14.6M Sell
185,020
-31,869
-15% -$2.27M 0.25% 85
2023
Q3
$15.1M Sell
216,889
-6,257
-3% -$443K 0.26% 91
2023
Q2
$15.4M Buy
223,146
+33,500
+18% +$2.38M 0.23% 89
2023
Q1
$14.1M Hold
189,646
0.23% 87
2022
Q4
$17.7M Sell
189,646
-347,100
-65% -$33.5M 0.32% 74
2022
Q3
$51.2M Buy
536,746
+25,509
+5% +$2.53M 1% 34
2022
Q2
$47.4M Sell
511,237
-90,983
-15% -$8.88M 0.84% 39
2022
Q1
$61M Buy
602,220
+107,470
+22% +$11.3M 0.86% 38
2021
Q4
$51M Buy
494,750
+51,561
+12% +$4.76M 0.66% 52
2021
Q3
$37.6K Buy
443,189
+84,975
+24% +$7.12M 0.44% 65
2021
Q2
$29.9M Buy
358,214
+21,908
+7% +$1.79M 0.42% 69
2021
Q1
$25.3M Sell
336,306
-1,038
-0.3% -$75.6K 0.39% 74
2020
Q4
$23M Buy
337,344
+44,346
+15% +$2.88M 0.49% 61
2020
Q3
$17.1M Sell
292,998
-26,300
-8% -$1.64M 0.51% 62
2020
Q2
$20.7M Sell
319,298
-46,211
-13% -$2.91M 0.74% 45
2020
Q1
$21.8M Buy
365,509
+127,122
+53% +$8.49M 0.93% 37
2019
Q4
$17.6M Buy
238,387
+3,984
+2% +$280K 0.66% 53
2019
Q3
$14.6M Buy
234,403
+13,438
+6% +$796K 0.62% 55
2019
Q2
$12.1M Buy
220,965
+33,409
+18% +$1.8M 0.51% 61
2019
Q1
$10.1M Sell
187,556
-28,974
-13% -$1.79M 0.42% 66
2018
Q4
$14.1M Buy
216,530
+24,205
+13% +$1.81M 0.65% 47
2018
Q3
$15.1M Buy
192,325
+27,896
+17% +$1.99M 0.59% 54
2018
Q2
$10.8M Buy
164,429
+43,660
+36% +$2.88M 0.46% 69
2018
Q1
$7.51M Sell
120,769
-711
-0.6% -$51K 0.35% 78
2017
Q4
$8.87M Sell
121,480
-9,081
-7% -$660K 0.59% 66
2017
Q3
$10.6M Buy
130,561
+6,449
+5% +$510K 0.82% 40
2017
Q2
$9.96M Buy
124,112
+5,134
+4% +$405K 0.84% 41
2017
Q1
$9.38M Buy
118,978
+6,470
+6% +$517K 0.8% 43
2016
Q4
$8.89M Buy
112,508
+42,516
+61% +$3.44M 0.82% 37
2016
Q3
$6.27M Buy
69,992
+47,744
+215% +$4.51M 0.54% 63
2016
Q2
$2.1M Hold
22,248
0.19% 112
2016
Q1
$2.31M Sell
22,248
-27,752
-56% -$2.7M 0.22% 105
2015
Q4
$4.94M Hold
50,000
0.42% 80
2015
Q3
$4.76M Buy
50,000
+6,700
+15% +$704K 0.44% 88
2015
Q2
$4.54M Hold
43,300
0.38% 97
2015
Q1
$4.5M Sell
43,300
-6,931
-14% -$701K 0.35% 106
2014
Q4
$4.9M Sell
50,231
-5,125
-9% -$452K 0.37% 104
2014
Q3
$4.43M Buy
55,356
+9,706
+21% +$765K 0.35% 102
2014
Q2
$3.46M Sell
45,650
-20,750
-31% -$1.57M 0.28% 111
2014
Q1
$4.93M Buy
66,400
+5,400
+9% +$381K 0.43% 72
2013
Q4
$4.37M Buy
+61,000
New +$3.92M 0.39% 74

Other funds holding CVS

Robeco Schweiz's CVS Position: Q2 2026 in Review

Robeco Schweiz reduced its CVS Health (CVS) stake by 15% in Q2 2026, selling an estimated $849K and leaving 52,254 shares worth $5.41M. The position accounts for 0.09% of the portfolio, ranked #109.

Robeco Schweiz first reported a position in CVS in Q4 2013 and has held it in 51 quarters since. The position peaked at $61M in Q1 2022. 1,271 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Robeco Schweiz held 52,254 shares of CVS Health worth $5.41M as of Q2 2026.
  • Robeco Schweiz sold 9,507 CVS Health shares in Q2 2026, an estimated $849K.
  • CVS Health made up 0.09% of Robeco Schweiz's portfolio in Q2 2026, its #109 holding.
  • Robeco Schweiz first reported a position in CVS Health in Q4 2013 and has held it in 51 quarters since.
  • Robeco Schweiz's CVS Health position peaked at $61M in Q1 2022.
  • 1,271 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Robeco Schweiz's 13F filing for Q2 2026, filed 28 Jul 2026.